Search results
Argatroban (Argatra®) Plasma Calibrator
Calibrating the assays of argatroban using clotting anti-IIa methods, especially when the HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) is used, with the low range protocol.
Dabigatran (Pradaxa®) Plasma Calibrator (low range)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma (e.g. Dabigatran Plasma Calibrator (ref. 222801), Dabigatran Control Plasma (ref. 224701), Argatroban Plasma Calibrator (ref. SC030K), Argatroban Control Plasma (ref. SC035K)).
Dabigatran (Pradaxa®) Plasma Calibrator
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma (e.g. Dabigatran Plasma Calibrator (ref. 222801), Dabigatran Control Plasma (ref. 224701), Argatroban Plasma Calibrator (ref. SC030K), Argatroban Control Plasma (ref. SC035K).
CRYOcheck™ CorPac™, frozen
CRYOcheck CorPacTM consists of 30 individual vials containing human plasma with distinct prothrombin time (PT), activated partial thromboplastin time (aPTT) and fibrinogen profiles spanning the normal and pathological range.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
Factor VII Deficient Plasma
Measurement of factor VII (FVII / proaccelerin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FVII deficient plasma is required